We are live on
!
Find out more
ACP
Ashfield Capital Partners Portfolio holdings
AUM
$1.19B
1-Year Est. Return
14.56%
This Fund
S&P 500
This Quarter
Est. Return
+0.1%
1 Year Est. Return
-14.56%
3 Year Est. Return
+48.8%
5 Year Est. Return
+97.38%
10 Year Est. Return
–
AUM
$769M
AUM Growth
-$8.78M
(-1.1%)
Cap. Flow
-$2.08M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
25.41%
Holding
255
New
5
Increased
91
Reduced
97
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$1.92M |
| 2 |
Blackrock
BLK
|
+$1.5M |
| 3 |
Vanguard Total International Stock ETF
VXUS
|
+$1.02M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$959K |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$939K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AB InBev
BUD
|
+$3.67M |
| 2 |
CELG
Celgene Corp
CELG
|
+$1.77M |
| 3 |
SHPG
Shire pic
SHPG
|
+$1.74M |
| 4 |
COL
Rockwell Collins
COL
|
+$1.15M |
| 5 |
Vanguard Intermediate-Term Bond ETF
BIV
|
+$863K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.34% |
| 2 | Healthcare | 17% |
| 3 | Industrials | 10.36% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Communication Services | 8.19% |
Similar funds
MCM
DWM
H6H
SIM
AIL
CL
CCP
RIG
Ashfield Capital Partners's Q1 2018 Portfolio in Review
As of Q1 2018, Ashfield Capital Partners held 255 positions worth $769M, down 1.1% from $777M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ashfield Capital Partners's Q1 2018 filing shows 5 new, 91 increased, 97 reduced and 10 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 10,282 shares worth $902K. The largest sale was AB InBev, an estimated $3.67M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.
- Ashfield Capital Partners's largest Q1 2018 buy was State Street SPDR S&P Biotech ETF: 10,282 shares worth $902K.
- Ashfield Capital Partners added most to Walmart Inc in Q1 2018, an estimated $1.92M increase.
- Ashfield Capital Partners's biggest Q1 2018 reduction was Celgene Corp, cutting an estimated $1.77M.
- Ashfield Capital Partners fully exited AB InBev in Q1 2018, selling an estimated $3.67M.
- Ashfield Capital Partners's ten largest holdings make up 25% of its $769M portfolio in Q1 2018.
- Ashfield Capital Partners opened 5 new positions and closed 10 in Q1 2018.
- Ashfield Capital Partners's portfolio value fell 1.1% quarter-over-quarter to $769M.
Based on Ashfield Capital Partners's 13F filing for Q1 2018, filed 2 May 2018.